{"id":5445,"date":"2010-10-07T11:43:36","date_gmt":"2010-10-07T02:43:36","guid":{"rendered":"http:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/contents\/?p=163"},"modified":"2010-10-07T11:43:36","modified_gmt":"2010-10-07T02:43:36","slug":"2009%e5%b9%b4%e6%a5%ad%e7%b8%be%e3%80%80%e3%81%9d%e3%81%ae1","status":"publish","type":"post","link":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/%e7%a0%94%e7%a9%b6%e7%b4%b9%e4%bb%8b\/5445\/","title":{"rendered":"2009\u5e74\u696d\u7e3e\u3000\u305d\u306e1"},"content":{"rendered":"

\u25a0\u8ad6\u6587\u30fb\u8457\u66f8
\n\u539f\u8457\u8ad6\u6587<\/a>
\n\u7dcf\u8aac, \u4ed6<\/a>
\n\u75c7\u4f8b\u5831\u544a<\/a>
\n\u8457\u66f8<\/a>
\n\u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868
\n\u56fd\u969b\u5b66\u4f1a<\/a>
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09<\/a>
\n\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09<\/a>
\n\u25a0 \u8b1b\u6f14<\/a>
\n\u25a0 \u7814\u7a76\u52a9\u6210<\/a>
\n\u25a0 \u53d7\u8cde<\/a>
\n—————————
\n\u25a0<\/span> \u8ad6\u6587\u30fb\u8457\u66f8<\/strong>
\n<\/a>\u25cf<\/span> \u539f\u8457\u8ad6\u6587
\n1. Kiriyama I, Miki H, Kikuchi K, Ohue S, Matsuda S, Mochizuki T. Topographic analysis of the inferior parietal lobule in high-resolution 3D MR imaging. AJNR Am J Neuroradiol. 2009 Mar 30(3): 520-4, 2009 [PubMed]<\/a>
\n2. Hamamoto Y, Kataoka M, Semba T, Uwatsu K, Sugawara Y, Inoue T, Sakai S, Aono S, Takahashi T, Oda S. Vertebral metastases with high risk of symptomatic malignant spinal cord compression Jpn J Clin Oncol 39: 431-434, 2009 [PubMed]<\/a>
\n3. Hamamoto Y, Kataoka M, Semba T, Uwatsu K, Sugawara Y, Inoue T, Sakai S, Aono S, Takahashi T, Oda S. Supraclavicular failure after breast-conserving therapy in patients with four or more positive axillary lymph nodes when prophylactic supraclavicular irradiation is omitted Jpn J Radiol 27: 213-217, 2009 [PubMed]<\/a>
\n4. Hamamoto Y, Kataoka M, Senba T, Uwatsu K, Oda S, Takahashi T, Aono S, Sakai S, Inoue T, Sugawara Y. Incidence and patterns of isolated brain failure in stage III non-small-cell lung cancer treated with concurrent chemoradiation tharapy Jpn J Radiol 27: 25-30, 2009 [PubMed]<\/a>
\n5. Hamamoto Y, Kataoka M, Yamashita M, Shinkai T, Kubo Y, Sugawara Y, Inoue T, Sakai S, Aono S, Takahashi T, Semba T, Uwatsu K. Local control of metastatic lung tumors treated with SBRT of 48 Gy in four fractions: in comparison with primary lung cancer Jpn J Clin Oncol : Epub aheqad of print, 2009 [PubMed]<\/a>
\n6. Matsumoto K, Ando M, Yamauchi C, Egawa C, Hamamoto Y, Kataoka M, Shuto T, Karasawa K, Kurosumi M, Kan N, Mitsumori M. Questionnaire survey of treatment choice for breast cancer patients with brain metastasis in Japan: results of a nationwide survey by the task force of the Japanese Breast Cancer Society. Jpn J Clin Oncol 39(1): 22-6, 2009 [PubMed]<\/a>
\n7. Inoue Y, Yang X, Nagao M, Higashino H, Hosokawa K, Kido T, Kurata A, Okayama H, Higaki J, Mochizuki T, Murase K.. Peri-infarct dysfunction in post-myocardial infarction: assessment of 3-T tagged and late enhancement MRI. Eur Radiol Nov 14: [Epub ahead of print], 2009 [PubMed]<\/a>
\n8. Kumano S, Uemura M, Haraikawa T, Hirata M, Kikuchi K, Kim T, Okada M, Mochizuki T, Murakami T. Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular carcinoma. Jpn J Radiol 27(6): 229-36, 2009 [PubMed]<\/a>
\n9. Nagao M, Matsuoka H, Kawakami H, Higashino H, Mochizuki T, Ohshita A, Kohno T, Shigemi S. Detection of myocardial ischemia using 64-slice MDCT. Circulation Journal 73(5): 905-11, 2009 [PubMed]<\/a>
\n10. Nagao M, Matsuoka H, Kawakami H, Higashino H, Mochizuki T, Uemura M, Shigemi S. Myocardial ischemia in acute coronary syndrome: assessment using 64-MDCT. AJR Am J Roentgenol 193(4): 1097-106, 2009 [PubMed]<\/a>
\n11. Furuya K, Maeda T, Nakanura S, Kikuchi T. The role of computer-aided 3-dimensional analytic tools and virtual microscopy in the investigation of radiologic-pathologic correlation. Arch Pathol Lab Med. 133(6): 912-915, 2009 [PubMed]<\/a>
\n12. Hiraoka A, Kogame M, Sogabe I, Ishimaru Y, Kashihara K, Miyagawa M, et al. Risk factors for death in 224 cases of hepatocellular carcinoma after transcatheter arterial chemoembolization. Hepato-gastroenterology 56: 213-217, 2009 [PubMed]<\/a>
\n13. Hiraoka A, Michitaka K, Horiike N, Hidaka S, Uehara T, Ichikawa S, Hasebe A, Miyamoto Y, Ninomiya T, Sogabe I, Ishimaru Y, Kawasaki H, Koizumi Y, Hirooka M, Yamashita Y, Abe M, Hiasa Y, Matsuura B, Onji M. Radiofrequency ablation therapy for hepatocellular carcinoma in elderly patients. J Gastroenterol Hepatol. 25(2): 403-407, 2009 [PubMed]<\/a>
\n14. Saito M, Miyagawa M, .et al. High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity. Diabetes 58: 1526-1531, 2009 [PubMed]<\/a>
\n15. \u6ff1\u672c\u3000\u6cf0, \u7247\u5ca1\u6b63\u660e, \u4ed9\u6ce2\u8cb4\u654f, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u83c5\u539f\u656c\u6587, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9752\u91ce\u7965\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u57ce\u6238\u502b\u4e4b \u9577\u6642\u9593\u64ae\u50cfCT\u306b\u3088\u308b\u4f53\u5185\u6a19\u7684\u4f53\u7a4d\u306e\u7cbe\u5ea6\u3092\u640d\u306d\u308b\u56e0\u5b50 \u81e8\u5e8a\u653e\u5c04\u7dda 54: 1264-1267, 2009 [CiNii]<\/a>
\n16. \u9577\u5c3e\u5145\u5c55, \u677e\u5ca1\u5b8f, \u5ddd\u4e0a\u79c0\u751f, \u5927\u4e0b\u6643, \u6cb3\u91ce\u73e0\u7f8e, \u91cd\u898b\u664b, \u4e0a\u6751\u96c5\u5f66, \u5fb3\u6c38\u4f38\u5b50, \u6771\u91ce\u535a, \u671b\u6708\u8f1d\u4e00. 64\u5217MDCT\u306e\u5fc3\u7b4b\u30a4\u30e1\u30fc\u30b8\u306b\u3088\u308b\u6025\u6027\u51a0\u75c7\u5019\u7fa4\u306e\u8a55\u4fa1\u3000\u5b89\u9759\u6642\u5fc3\u7b4b\u8840\u6d41\u30b7\u30f3\u30c1\u30b0\u30e9\u30d5\u30a3\u3068\u306e\u6bd4\u8f03. \u5fc3\u81d3 41\/5: 514-520, 2009 [\u5fc3\u81d3]<\/a>
\n<\/a>\u25cf<\/span> \u7dcf\u8aac, \u4ed6
\n1. Gregory S. Hurlock, Hiroshi Higashino, Teruhito Mochizuki. History of Cardiac Computed Tomography: Single to 320-Detector RowMultislice Computed Tomography. Int J Cardiovasc Imaging 15: 31-42, 2009 [PubMed]<\/a>
\n2. \u57ce\u6238\u8f1d\u4ec1. MSCT\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u8a55\u4fa1\uff5e\u3053\u308c\u307e\u3067\u306e\u691c\u8a0e\u3068Dual Energy Imaging\u306e\u53ef\u80fd\u6027\uff5e INNERVISION 284: 14-18, 2009 [INNERVISION]<\/a>
\n3. \u57ce\u6238\u8f1d\u4ec1. Philips256\u5217iCT\u306e\u7279\u5fb4\u3068\u5fc3\u81d3\u9818\u57df\u306b\u304a\u3051\u308b\u4f7f\u7528\u7d4c\u9a13 Rad Fan 7(13): 30-32, 2009 [RadFan]<\/a>
\n4. \u57ce\u6238\u8f1d\u4ec1. \u30d5\u30a3\u30ea\u30c3\u30d7\u30b9\u793e\u88fdMDCT\u3092\u7528\u3044\u305f\u5fc3\u81d3CT\u306e\u753b\u50cf\u8a3a\u65ad Rad Fan 7(3): 45-48, 2009 [RadFan]<\/a>
\n5. \u5009\u7530\u3000\u8056. CT\u3092\u7528\u3044\u305f\u5fc3\u7b4b\u30d0\u30a4\u30a2\u30d3\u30ea\u30c6\u30a3\u3068\u5fc3\u7b4b\u865a\u8840\u306e\u8a3a\u65ad Rad Fan 3: 59-62, 2009 [RadFan]<\/a>
\n6. \u5009\u7530\u3000\u8056. \u65b0\u4e16\u4ee3MDCT\u306b\u671f\u5f85\u3067\u304d\u308b\u3053\u3068\u30004\uff09 256\u30b9\u30e9\u30a4\u30b9iCT Rad Fan 10: 23-26, 2009 [RadFan]<\/a>
\n7. \u671b\u6708\u8f1d\u4e00, \u6771\u91ce\u535a, \u5175\u982d\u670b\u5b50. \u753b\u50cf\u8a3a\u65ad\u306e\u9032\u6b69\u306b\u3064\u3044\u3066. \u611b\u5a9b\u533b\u5b66 28: 177-186, 2009
\n8. \u6771\u91ce \u535a, \u671b\u6708 \u8f1d\u4e00. \u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65ad2009 \u4f01\u753b\u3000\u5faa\u74b0\u5668\u753b\u50cf\u8a3a\u65adUp to Date. Rad Fan 7(3): , 2009 [RadFan]<\/a>
\n9. \u6771\u91ce \u535a. \u9ad8\u78c1\u5834MRI\u304c\u3082\u305f\u3089\u3059\u5fc3\u81d3MR\u691c\u67fb\u306e\u5148\u9032\u6027 \u30bf\u30ae\u30f3\u30b0\u6cd5\u30b7\u30cdMR\u306e\u9032\u6b69. \u65b0\u533b\u7642 414: 57-59, 2009
\n<\/a>\u25cf<\/span> \u75c7\u4f8b\u5831\u544a
\n1. Hyodo T, Sugawara Y, Tsuda T, Yanagihara Y, Aoki K, Tanji N, Hirata M, Murakami M, Miyagawa M, Yokoyama M, Mochizuki T. Widespread metastases from sarcomatoid renal cell carcinoma detected by (18)F-FDG positron emission tomography\/computed tomography. Jpn J Radiol 27: 111-4, 2009 [PubMed]<\/a>
\n2. Sakayama K, Kidani T, Sugawara Y, Tauchi H, Fujibuchi T, Tanji N, Yamamoto H, Tsuchiya H. Reconstruction using a frozen bone method for osteosarcoma of the talus. A case report and review of the literature Anticancer Res 29: 4093-4098, 2009 [PubMed]<\/a>
\n3. \u6a2a\u5c71\u96c4\u4e00\u90ce\u3001\u4f50\u85e4\u6674\u745e\u3001\u5009\u7530\u3000\u8056\u3001\u6771\u91ce\u3000\u535a\u3001\u963f\u90e8\u5145\u4f2f \u5185\u81d3\u9006\u4f4d\u306b\u5bfe\u3059\u308b\u8907\u5408\u5fc3\u81d3\u5916\u79d1\u624b\u8853\u306bMDCT \u306b\u3088\u308b\u8853\u524d\u8a55\u4fa1\u304c\u6709\u7528\u3067\u3042\u3063\u305f1\u4f8b. DIGITAL MEDICINE 42: 36, 2009
\n4. \u8d77\u585a\u9999\u5b50, \u5409\u5ca1\u771f\u4e8c, \u6e05\u6c34\u8f1d\u5f66, \u6d66\u5cf6\u96c4\u4ecb, \u6751\u7530\u7e41\u5229. \u809d\u5185\u80c6\u7ba1\u7d30\u80de\u764c\u3068\u9451\u5225\u304c\u56f0\u96e3\u3067\u3042\u3063\u305f\u80c6\u7ba1\u5185\u767a\u80b2\u578b\u809d\u7d30\u80de\u764c\u306e\u4e00\u4f8b. \u81e8\u5e8a\u653e\u5c04\u7dda : in press, 2010
\n5. \u5c0f\u7530\u5c1a\u543e, \u83c5\u539f\u656c\u6587, \u9752\u91ce\u7965\u53f8, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u6749\u539f\u9032\u4ecb, \u5bfa\u672c\u5178\u5f18. \u4ed9\u9aa8\u524d\u9762\u306b\u767a\u751f\u3057\u305f\u6de1\u660e\u7d30\u80de\u8089\u816b\u306e1\u4f8b \u81e8\u5e8a\u653e\u5c04\u7dda 54: 1036-1039, 2009
\n6. \u6b66\u667a\u6075, \u5409\u5ca1\u771f\u4e8c, \u6d66\u5cf6\u96c4\u4ecb, \u677e\u5742\u667a\u7f8e, \u6e05\u6c34\u8f1d\u5f66, \u6751\u7530\u7e41\u5229. \u7279\u7570\u306a\u5f62\u614b\u3092\u5448\u3057\u305f\u809d\u5185\u80c6\u7ba1\u764c. \u81e8\u5e8a\u653e\u5c04\u7dda 54: 897-901, 2009
\n7. \u6b66\u667a\u6075, \u5409\u5ca1\u771f\u4e8c, \u6d66\u5cf6\u96c4\u4ecb, \u6e05\u6c34\u8f1d\u5f66, \u6751\u7530\u7e41\u5229. \u975e\u5b9a\u578b\u7684\u306a\u7d4c\u904e\u3092\u305f\u3069\u3063\u305f\u76f4\u9759\u8108\u6d1e\u8840\u6813\u75c7\u306e\u4e00\u4f8b. \u81e8\u5e8a\u653e\u5c04\u7dda : in press, 2010
\n8. \u6b66\u667a\u6075, \u5409\u5ca1\u771f\u4e8c, \u677e\u5742\u667a\u7f8e, \u6e05\u6c34\u8f1d\u5f66, \u6d66\u5cf6\u96c4\u4ecb, \u6751\u7530\u7e41\u5229. \u7279\u7570\u306a\u9032\u5c55\u5f62\u5f0f\u3092\u5448\u3057\u305f\u80c6\u56a2\u764c. \u81e8\u5e8a\u653e\u5c04\u7dda 54: 787-791, 2009
\n9. \u4e95\u4e0a\u7950\u99ac, \u6771\u91ce\u535a, \u671b\u6708\u8f1d\u4e00. \u5fc3\u30b5\u30eb\u30b3\u30a4\u30c9\u30fc\u30b7\u30b9. Rad Fan 7\/6: 8-9(1348-3498), 2009
\n10. \u7d30\u5ddd\u6d69\u5e73,\u671b\u6708\u8f1d\u4e00. \u4e0d\u6574\u8108\u539f\u6027\u53f3\u5ba4\u5fc3\u7b4b\u75c7. \u753b\u50cf\u8a3a\u65ad\u3000\u79c0\u6f64\u793e 29: 82-84, 2009
\n11. \u6ff1\u672c\u6cf0, \u7247\u5ca1\u6b63\u660e, \u65b0\u6d77\u54f2, \u4ed9\u6ce2\u8cb4\u654f, \u4e0a\u6d25\u5b5d\u592a\u90ce T1-2N0\u80f8\u90e8\u75c5\u5909\u3068\u8133\u5358\u72ec\u8ee2\u79fb\u3092\u6709\u3059\u308bIV\u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306b\u5bfe\u3059\u308b\u80ba\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\uff0d2\u4f8b\u306e\u7d4c\u9a13\uff0d. \u81e8\u5e8a\u653e\u5c04\u7dda 54: 1791-1794, 2009
\n<\/a>\u25cf<\/span> \u8457\u66f8
\n1. \u6771\u91ce \u535a, \u671b\u6708 \u8f1d\u4e00 \u5fc3\u6a5f\u80fd\u8a55\u4fa1 CT \u898b\u3066\u8a3a\u3066\u5b66\u3076 \u865a\u8840\u6027\u5fc3\u75be\u60a3\u306e\u753b\u50cf\u8a3a\u65ad : 227-236, 2009
\n2. \u6771\u91ce \u535a, \u671b\u6708 \u8f1d\u4e00 \u5fc3\u81d3CT\u3067\u5fc3\u7b4b\u3092\u8a55\u4fa1\u3057\u3088\u3046 ! \u5fc3\u81d3\u8840\u7ba1\u753b\u50cfMOOK2 : 46-53, 2009
\n\u25a0<\/span> \u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868<\/strong>
\n<\/a>\u25cf<\/span> \u56fd\u969b\u5b66\u4f1a
\n1. Tsuda T, Hyodo T, Hirata M, Okizuka Y, Murakami M, Mochizuki T. Prevalence of splenic artery aneurysms by interactive 3D CT angiography using image viewer provided with MIP and MPR software. European Congress of Radiology 2009 (2009. 3, Vienna)
\n2. Inoue Y, Nagao M, Yang X, Higashino H, Kido T, Kurata A, Mochizuki T, Okayama H, Murase K Assessment of Regional Strain in Myocardial Infarction Using 3T Tagged and Late Enhancement MRI. The 3rd Congress of Asian Society of Cardiovascular Imaging (2009. 6, Tokyo)
\n3. Hosokawa K, Kido T, Kurata A, Inoue Y, Nagao M, Higashino H, Mochizuki T. Standardized Coronary 64-slice CT Angiography Using the Diluted Contrast Medium . The 3rd Congress of Asian Society of Cardiovascular Imaging (2009. 6, Tokyo)
\n4. Inoue Y, Kurata A,\u3000Hosokawa K,\u3000Kido T,\u3000Nagao M,\u3000Higashino H,\u3000Mochizuki T, et al. Incremental Enhancement of Aortic Atherosclerotic Plaques Evaluated by MDCT. The 4th Annual Scientific Meeting Society of Cardiovascular Computed Tomography (2009. 7, Orland)
\n5. Kido T, Inoue R, Hosokawa K,Kurata A, Inoue Y, Higashino H, Mochizuki T, Higaki J Standardization of Contrast Medium Injection Protocol for 64-slice Coronary CT Angiography: A Test Injection of Diluted Contrast Medium. The 4th Annual Scientific Meeting Society of Cardiovascular Computed Tomography (SCCT) (2009. 7, Orland)
\n6. Kido T, Kurata A, Inoue Y, Higashino H, Mochizuki T, Higaki J Dual energy CT for the assessment of Myocardial ischemia using ATP. The 4th Annual Scientific Meeting Society of Cardiovascular Computed Tomography (SCCT) (2009. 7, Orland)
\n7. Nagao M, Higashino H, Kido T, Kurata H, Inoue Y, Hosokawa K, Mochizuki T, et al. Myocardial ischemia in acute coronary syndrome: assessment using 64-slice MDCT. The 4th Annual Scientific Meeting Society of Cardiovascular Computed Tomography (2009. 7, Orland)
\n8. Hosokawa K, Kurata A, Kido T, Inoue Y, Nagao M, Higashino H, Mochizuki T. Evaluation of the Left Ventricular Torsion by Multidetector-row Computed Tomography. The 4th Annual Scientific Meeting Society of Cardiovascular Computed Tomography (SCCT) (2009. 7, Orland)
\n9. Hirata M, Tanaka H, Hyoudo T, Tsuda T, Mochizuki T. The strategy of partial splenic embolization using angio-CT system equipped with 16-channel MDCT. The 9th Cardiovascular and Interventional Radiological Society of Europe (CIRSE) (2009. 9, Portugal)
\n10. Miki H, Igase K, Matsubara I, Kiriyama I, Sadamaoto K, Mochizuki T Unruptured Intracranial Aneurysms; Detection and Follow-up on 3.0T MRA. \u7b2c21\u56de\u56fd\u969bMRA\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7 (2009. 9, East Lansing)
\n11. Hamamoto Y, Kataoka M, Semba T, Uwatsu K Factors Affect the Survival Time after Recurrence in Stage III Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy. The 51st American Society for Therapeutic Radiation Oncology annual meeting (2009. 11, Chicago)
\n12. Hosokawa K, Kido T, Kurata A, Nagao M, Higashino H, Mochizuki T. Late Myocardial Enhancement by MDCT in Myocardial Infarction Compared with MRI. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n13. Hyodo T, Okizuka Y, Hirata M, Tanaka H, Tsuda T, Mochizuki T. Gastrografin CT Enterography (G-CTE): A Minimally Invasive Method for Small Bowel Disorders. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n14. Kido T, Kurata A, Hosokawa K, Inoue Y, Nagao M, Higashino H, Mochizuki T. Quantitative Evaluation of Regional Myocardial Blood Flow of the Left Ventricle Using Adenosine Triphosphate Stress 64-row Multidetector Computed Tomography in Pre- and Post-coronary Artery Bypass Grafting. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n15. Miki H, Kiriyama I, Oda S, Igase K, Matsubara I, Sadamoto K, Mochizuki T. Screening for Unruptured Intracranial Aneurysms on 3.0T MR Angiography. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n16. Nakajima N, Nagao M, Higashino H, Inoue Y, Hosokawa K, Kurata A, Mochizuki T. Assessment of Myocardial Ischemia in Acute Coronary Syndrome Using 64-slice MDCT: Comparison with Myocardial Perfusion Scintigraphy and Late Enhance MRI. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n17. Oda S, Hiratsuka Y, Sadamoto K, Kikuchi K, Miki H, Mochizuki T. The Diagnostic Accuracy for Intracranial Aneurysms on 3T MRA and 64-MDCTA: Evaluation of False Negative Cases. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n18. Taguchi S, Nichikawa A, Ochi T, Fujii T, Mochizuki T. Prognostic Assessment of Primary Central Nervous System Lymphoma: Single Institute Experience. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n19. Tsuda T, Hyodo T, Hirata M, Tanaka H, Mochizuki T. Precise 3D CT Enterography by Fusion Volume Rendering Image of Both Positive Oral Contrast Agent and Air-filled Space for the Evaluation of Crohns Disease. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n20. Tsuda T, Hyodo T, Hirata M, Tanaka H, Mochizuki T. Enhancement of Portal Vein and Hepatic Vein on Triple-Phase Dynamic CT among Three Groups Consisting of Non-cirrhotic Patients and Cirrhotic Patients with and without Collateral Vessels. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n21. Kiriyama I, Miki H, Kikuchi K, Ohue S, Matsuda S, Mochizuki T. Topographic analysis of the inferior parietal lobule in high-resolution 3D MR imaging. The RSNA 95th Scientific Assembly and Annual Meeting (2009. 12, Chicago)
\n<\/a>\u25cf<\/span> \u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09
\n1. \u5c0f\u7530\u5c1a\u543e, \u83c5\u539f\u656c\u6587, \u9752\u91ce\u7965\u53f8, \u4e95\u4e0a\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0. \u4ed9\u9aa8\u524d\u90e8\u306b\u767a\u751f\u3057\u8853\u524d\u8a3a\u65ad\u304c\u56f0\u96e3\u3067\u3042\u3063\u305fclear cell sarcoma of soft tissue\u306e\uff11\u4f8b. \u7b2c20\u56de\u9aa8\u8edf\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2009. 1, \u6771\u4eac)
\n2. \u83c5\u539f\u656c\u6587, \u5c0f\u7530\u5c1a\u543e, \u9ad8\u6a4b\u5fe0\u7ae0, \u9752\u91ce\u7965\u53f8, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u4ed9\u6ce2\u8cb4\u654f, \u6749\u539f\u9032\u4ecb, \u6cbc\u672c\u90a6\u5f66, \u9ad8\u7551\u6d69\u4e4b, \u897f\u6751\u7406\u6075\u5b50, \u5bfa\u672c\u5178\u5f18. \u826f\u60aa\u6027\u306e\u8a3a\u65ad, \u4eca\u5f8c\u306e\u6cbb\u7642\u65b9\u91dd\u306b\u82e6\u616e\u3057\u3066\u3044\u308b\u4ed9\u9aa8\u9aa8\u816b\u760d\u306e1\u4f8b. \u7b2c20\u56de\u9aa8\u8edf\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2009. 1, \u6771\u4eac)
\n3. \u6ff1\u672c\u3000\u6cf0, \u7247\u5ca1\u6b63\u660e, \u4ed9\u6ce2\u8cb4\u654f, \u4e0a\u6d25\u5b5d\u592a\u90ce . \u80ba\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u3092\u65bd\u884c\u3057\u305f\u539f\u767a\u6027\u80ba\u764c\u3068\u8ee2\u79fb\u6027\u80ba\u764c\u306e\u6cbb\u7642\u6210\u7e3e . \u7b2c19\u56de\u65e5\u672c\u9ad8\u7cbe\u5ea6\u5916\u90e8\u7167\u5c04\u7814\u7a76\u4f1a (2009. 1, \u540d\u53e4\u5c4b)
\n4. \u4e95\u4e0a\u7950\u99ac, \u9577\u5c3e\u5145\u5c55, \u6771\u91ce\u535a, \u7d30\u5ddd\u6d69\u5e73, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00, \u6751\u702c\u7814\u4e5f\u3000\u4ed6. Assessment of Regional Strain in Myocardial Infarction Using 3T Tagged and Late Enhancement MRI. \u7b2c73\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a (2009. 3, \u5927\u962a)
\n5. \u7d30\u5ddd\u6d69\u5e73,\u57ce\u6238\u8f1d\u4ec1,\u5009\u7530\u8056,\u4e95\u4e0a\u7950\u99ac,\u9577\u5c3e\u5145\u5c55,\u6771\u91ce\u535a,\u671b\u6708\u8f1d\u4e00. \u9045\u5ef6\u9020\u5f71\u306b\u3088\u308b\u5fc3\u7b4b\u6897\u585e\u691c\u51fa\u80fd -CT\u3068MRI\u306e\u6bd4\u8f03-. \u7b2c73\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a (2009. 3, \u5927\u962a)
\n6. \u9577\u5c3e\u5145\u5c55, \u6771\u91ce\u535a, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u4e95\u4e0a\u7950\u99ac, \u7d30\u5ddd\u6d69\u5e73, \u671b\u6708\u8f1d\u4e00\u4ed6. Assessment of myocardial ischemia in acute coronary syndrome using 64-slice MDCT myocardial imaging. \u7b2c73\u56de\u65e5\u672c\u5faa\u74b0\u5668\u5b66\u4f1a\u7dcf\u4f1a\u30fb\u5b66\u8853\u96c6\u4f1a (2009. 3, \u5927\u962a)
\n7. \u7530\u5ddd\u96c5\u5f66, \u798f\u672c\u771f\u4e5f, \u4e45\u9580\u826f\u660e, \u5927\u897f\u4e18\u502b, \u4e09\u6728\u3000\u5747, \u83ca\u6c60\u6075\u4e00. Black blood\u6cd5\u306b\u3088\u308bT1\u5f37\u8abf\u50cf\u3092\u7528\u3044\u305f\u30d7\u30e9\u30fc\u30af\u8a3a\u65ad\u306b\u3088\u308bCAS\u5f8c\u306edistal embolism\u4e88\u6e2c\u306e\u8a66\u307f. \u7b2c32\u56de\u65e5\u672c\u8133\u795e\u7d4cCI\u5b66\u4f1a\u7dcf\u4f1a (2009. 3, \u4eac\u90fd)
\n8. \u5c71\u4e0b\u5927\u4ecb, \u5927\u4e0a\u53f2\u6717, \u9ad8\u91ce\u660c\u5e73, \u539f\u7530\u5e83\u4fe1, \u4e45\u9580\u826f\u660e, \u5927\u897f\u4e18\u502b, \u4e09\u6728\u3000\u5747, \u83ca\u6c60\u6075\u4e00. \u4e2d\u5fc3\u524d\u56de\u540c\u5b9a\u306b\u304a\u3051\u308bMRI\u306e\u6709\u7528\u6027-MRI\u5404\u7a2e\u753b\u50cf\u8a3a\u65ad\u6cd5\u3068\u8853\u4e2d\u8a3a\u65ad\u3068\u306e\u5bfe\u6bd4. \u7b2c32\u56de\u65e5\u672c\u8133\u795e\u7d4cCI\u5b66\u4f1a\u7dcf\u4f1a (2009. 3, \u4eac\u90fd)
\n9. \u5c0f\u7530\u5c1a\u543e, \u4e09\u6728\u5747. \u80a5\u539a\u6027\u786c\u819c\u708e\u306e\u4e00\u4f8b. \u7b2c2\u56de\u810a\u690e\u30fb\u810a\u9ac4\u753b\u50cf\u30af\u30e9\u30d6 (2009. 4, \u6771\u4eac)
\n10. \u4e2d\u6751\u8aa0\u6cbb, \u83ca\u6c60\u9686\u5fb3, \u77f3\u4e38\u826f\u5e83, \u66fd\u6211\u90e8\u4e00\u90ce, \u677e\u6728\u5f18\u91cf, \u5c71\u4e0b \u606d, \u68b6\u539f \u8aa0, \u5c0f\u4e80\u96c5\u5e83, \u7530\u53e3\u5343\u85cf, \u5bae\u5ddd\u6b63\u7537. \u5c40\u6240\u8133\u8840\u6d41\u91cf\u5b9a\u91cf\uff1aSplit-dose\u6cd5\u306b\u304a\u3051\u308b1\u70b9\u9759\u8108\u63a1\u8840\u306e\u6709\u7528\u6027\u306e\u691c\u8a0e. \u7b2c62\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n11. \u4e95\u4e0a\u7950\u99ac, Xiaomei Yang, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u9577\u5c3e\u5145\u5c55, \u5ca1\u5c71\u82f1\u6a39, \u6771\u91ce\u535a, \u6a9c\u57a3\u5be6\u7537, \u671b\u6708\u8f1d\u4e00, \u6751\u702c\u7814\u4e5f. 3.0T MRI\u3092cine-tagging MRI\u306b\u3088\u308b\u5de6\u5ba4\u5fc3\u7b4bstrain\u306e\u5b9a\u91cf\u8a55\u4fa1\u6cd5\u306e\u691c\u8a0e. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n12. \u8d77\u585a\u9999\u5b50, \u5175\u982d\u670b\u5b50, \u5e73\u7530\u96c5\u662d, \u6751\u4e0a\u6b63\u54f2, \u6d25\u7530\u5b5d\u6cbb, \u671b\u6708\u8f1d\u4e00. \u30ac\u30b9\u30c8\u30ed\u30b0\u30e9\u30d5\u30a3\u30f3CT\u306b\u3088\u308b\u5c0f\u8178\u75be\u60a3\u306e\u8a55\u4fa1. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n13. \u7d30\u5ddd\u6d69\u5e73, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u4e95\u4e0a\u7950\u99ac, \u5ca1\u5c71\u82f1\u6a39, \u6a9c\u57a3\u5be6\u7537, \u6771\u91ce\u535a, \u671b\u6708\u8f1d\u4e00. \u9045\u5ef6\u9020\u5f71\u306b\u3088\u308b\u5fc3\u7b4b\u6897\u585e\u691c\u51fa\u80fd\uff1aCT\/MRI\u306e\u6bd4\u8f03. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n14. \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u4e95\u4e0a\u7950\u99ac, \u7d30\u5ddd\u6d69\u5e73, \u9577\u5c3e\u5145\u5c55, \u6771\u91ce\u535a, \u671b\u6708\u8f1d\u4e00. \u5e0c\u91c8\u9020\u5f71\u6cd5\u3092\u7528\u3044\u305f\u5fc3\u81d3CT\u306b\u304a\u3051\u308b\u9020\u5f71\u52b9\u679c\u6a19\u6e96\u5316\u306e\u8a66\u307f. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n15. \u5175\u982d\u670b\u5b50, \u8d77\u585a\u9999\u5b50, \u5e73\u7530\u96c5\u662d, \u6751\u4e0a\u6b63\u54f2, \u6d25\u7530\u5b5d\u6cbb, \u671b\u6708\u8f1d\u4e00. Gd-EOB-DTPA\u809d\u7d30\u80de\u76f8\u306b\u304a\u3051\u308b\u809d\u5185\u9580\u8108\u30fb\u9759\u8108\u306e\u63cf\u51fa\u80fd. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n16. \u4e95\u4e0a\u3000\u6b66, \u83c5\u539f\u656c\u6587, \u9152\u4e95\u4f38\u4e5f, \u9752\u91ce\u7965\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f, \u5c0f\u7530\u5c1a\u543e, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u6ff1\u672c\u3000\u6cf0, \u7247\u5ca1\u6b63\u660e. PET\/CT\u3092\u7528\u3044\u305f\u5c40\u6240\u9032\u884c\u4e73\u764c\u8853\u524d\u5316\u5b66\u88dc\u52a9\u7642\u6cd5\u5f8c\u306eCR\u5224\u5b9a. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n17. \u83c5\u539f\u656c\u6587, \u4e95\u4e0a\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9752\u91ce\u7965\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f, \u5c0f\u7530\u5c1a\u543e, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u6ff1\u672c\u6cf0, \u7247\u5ca1\u6b63\u660e. \u81b5\u5185\u5206\u6ccc\u816b\u760d\u306b\u304a\u3051\u308bFDG-PET\/CT\u306e\u6709\u7528\u6027\u3068\u9650\u754c. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n18. \u9752\u91ce\u7965\u53f8, \u83c5\u539f\u656c\u6587, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f, \u5c0f\u7530\u5c1a\u543e, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u7247\u5ca1\u6b63\u660e, \u6ff1\u672c\u3000\u6cf0. \u539f\u767a\u5de3\u3068\u8ee2\u79fb\u5de3\u3067FDG\u96c6\u7a4d\u306b\u4e56\u96e2\u304c\u898b\u3089\u308c\u308b\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n19. \u5e73\u585a\u7fa9\u5eb7, \u4e09\u6728\u5747, \u83ca\u6c60\u6075\u4e00, \u6850\u5c71\u90c1\u5b50, \u677e\u539f\u4e00\u90ce, \u8c9e\u672c\u548c\u5f66, \u671b\u6708\u8f1d\u4e00. 3T-MRI\u306b\u304a\u3051\u308b\u80fd\u52d5\u8108\u7624\u8a3a\u65ad\u7cbe\u5ea6\uff1a\u507d\u967d\u6027, \u507d\u9670\u6027\u306e\u691c\u8a0e. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u5b66\u8853\u767a\u8868\u4f1a (2009. 4, \u6a2a\u6d5c)
\n20. \u4e95\u4e0a\u7950\u99ac, \u9577\u5c3e\u5145\u5c55, \u6771\u91ce\u535a, \u7d30\u5ddd\u6d69\u5e73, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00, \u6751\u702c\u7814\u4e5f\u3000\u4ed6. 3.0T MRI\u3092\u7528\u3044\u305fcine-tagging MRI\u306b\u3088\u308b\u5fc3\u7b4bstrain\u306e\u5b9a\u91cf\u8a55\u4fa1\u306e\u691c\u8a0e. \u7b2c68\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u7dcf\u4f1a (2009. 4, \u6a2a\u6d5c)
\n21. \u767d\u77f3\u3000\u6cf0\u5b8f, \u672b\u56fd\u3000\u5b8f, \u5c0f\u5cf6\u3000\u660e\u5f66, \u4e0a\u7530\u3000\u5e78\u4ecb, \u5409\u672c\u3000\u653f\u5f18. \u65b0\u3057\u30443D\u64ae\u50cf\u6cd5\u306b\u3088\u308bBlack\u3000Blood\u3000Imaging\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u7b2c65\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a (2009. 4, \u6a2a\u6d5c)
\n22. \u5c0f\u7530\u5c1a\u543e, \u4e09\u6728\u5747, \u6850\u5c71\u90c1\u5b50, \u83ca\u6c60\u6075\u4e00. Anaplastic oligodendroglioma\u306e\u4e00\u4f8b. \u7b2c29\u56de\u795e\u7d4c\u653e\u5c04\u7dda\u30ef\u30fc\u30af\u30b7\u30e7\u30c3\u30d7 (2009. 6, \u5bae\u5d0e)
\n23. \u9577\u5c3e\u5145\u5c55, \u6771\u91ce\u535a, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u4e95\u4e0a\u7950\u99ac, \u7d30\u5ddd\u6d69\u5e73, \u671b\u6708\u8f1d\u4e00\u4ed6. 3T tagged MRI\u3068\u9045\u5ef6\u9020\u5f71\u306b\u3088\u308b\u5fc3\u7b4b\u6897\u585e\u5c40\u6240\u5909\u6a5f\u904b\u9053\u3068viability\u306e\u8a55\u4fa1. \u7b2c69\u56de\u5fc3\u81d3\u8840\u7ba1\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2009. 6, \u6771\u4eac)
\n24. \u4e95\u4e0a\u7950\u99ac,\u3000\u9577\u5c3e\u5145\u5c55,\u3000\u6771\u91ce\u535a,\u3000\u7d30\u5ddd\u6d69\u5e73,\u3000\u57ce\u6238\u8f1d\u4ec1,\u3000\u5009\u7530\u8056,\u3000\u671b\u6708\u8f1d\u4e00,\u3000\u6751\u702c\u7814\u4e5f\u3000\u4ed6. 3.0T MRI\u306b\u3088\u308b\u9673\u65e7\u6027\u5fc3\u7b4b\u6897\u585e\u75c7\u4f8b\u306b\u304a\u3051\u308b\u5fc3\u7b4bstrain\u3068\u9045\u5ef6\u9020\u5f71\u306e\u691c\u8a0e. \u7b2c17\u56de\u65e5\u672cMR Angiography\u7814\u7a76\u4f1a (2009. 6, \u5927\u962a)
\n25. \u5c0f\u7530\u5c1a\u543e, \u4e09\u6728\u5747, \u6850\u5c71\u90c1\u5b50, \u83ca\u6c60\u6075\u4e00, \u671b\u6708\u8f1d\u4e00, \u5e73\u585a\u7fa9\u5eb7, \u677e\u539f\u4e00\u90ce, \u8c9e\u672c\u548c\u5f66. 3T-MRA\u306b\u304a\u3051\u308b\u8133\u52d5\u8108\u7624\u8a3a\u65ad\u7cbe\u5ea6\uff1a\u507d\u9670\u6027\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c17\u56de\u65e5\u672cMR Angiography\u7814\u7a76\u4f1a (2009. 6, \u5927\u962a)
\n26. \u5c71\u4e0b \u606d,\u677e\u6728\u5f18\u91cf,\u7530\u53e3\u5343\u85cf,\u67cf\u539f\u8ce2\u4e00,\u5ddd\u4e2d\u3000\u5d07,\u5ddd\u53e3\u76f4\u4eba,\u5c0f\u4e80\u96c5\u5e83,\u68b6\u539f \u8aa0,\u66fd\u6211\u90e8\u4e00\u90ce,\u77f3\u4e38\u826f\u5e83,\u83ca\u6c60\u9686\u5fb3,\u4e2d\u6751\u8aa0\u6cbb,\u5bae\u5ddd\u6b63\u7537. \u5730\u65b9\u4e2d\u6838\u75c5\u9662\u306b\u304a\u3051\u308b\u5c0f\u5150\u306b\u5bfe\u3059\u308b\u653e\u5c04\u7dda\u6cbb\u7642\u306e\u5b9f\u60c5. \u7b2c45\u56de\u65e5\u672c\u5c0f\u5150\u653e\u5c04\u7dda\u5b66\u4f1a (2009. 6, \u9ad8\u677e)
\n27. \u5175\u982d\u670b\u5b50, \u5e73\u7530\u96c5\u662d, \u6751\u4e0a\u6b63\u54f2, \u6d25\u7530\u5b5d\u6cbb, \u671b\u6708\u8f1d\u4e00, \u5ee3\u5ca1\u660c\u53f2, \u5c71\u672c\u5b89\u5247, \u65e5\u6d45\u967d\u4e00, \u6069\u5730\u68ee\u4e00. \u809d\u81d3\u304a\u3088\u3073\u813e\u81d3\u306b\u591a\u767a\u816b\u7624\u3092\u5448\u3057\u305f\u7d44\u7e54\u7403\u8089\u816b\u306e1\u4f8b. \u7b2c23\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2009. 6, \u5ca1\u5c71)
\n28. \u9152\u4e95\u4f38\u4e5f, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u5c0f\u7530\u5c1a\u543e, \u4ed9\u6ce2\u8cb4\u654f, \u6ff1\u672c\u3000\u6cf0, \u9ad8\u6a4b\u5fe0\u7ae0, \u9752\u91ce\u7965\u53f8, \u4e95\u4e0a\u3000\u6b66, \u83c5\u539f\u656c\u6587, \u7247\u5ca1\u6b63\u660e, \u767d\u5c71\u88d5\u5b50, \u65e5\u6d66\u660c\u9053, \u5bfa\u672c\u5178\u5f18. \u8853\u524d\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u5de8\u5927\u306a\u5375\u7ba1\u764c\u306e\uff11\u4f8b. \u7b2c23\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2009. 6, \u5ca1\u5c71)
\n29. \u57ce\u6238\u502b\u4e4b, \u83c5\u539f\u656c\u6587, \u9752\u91ce\u7965\u53f8, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u6ff1\u672c\u3000\u6cf0, \u7247\u5ca1\u6b63\u660e, \u5927\u7530\u8015\u53f8, \u68da\u7530\u3000\u7a14, \u9ad8\u7551\u6d69\u4e4b, \u897f\u6751\u7406\u6075\u5b50, \u5bfa\u672c\u5178\u5f18. \u6f3f\u6db2\u6027\u56a2\u80de\u817a\u816b\u985e\u4f3c\u306e\u5185\u90e8\u69cb\u9020\u3092\u793a\u3057\u305f\u81b5\u5185\u5206\u6ccc\u816b\u760d\u306e1\u4f8b. \u7b2c23\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2009. 6, \u5ca1\u5c71)
\n30. \u83c5\u539f\u656c\u6587, \u57ce\u6238\u502b\u4e4b, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u9752\u91ce\u7965\u53f8, \u4ed9\u6ce2\u8cb4\u654f, \u5c0f\u7530\u5c1a\u543e, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u6ff1\u672c\u3000\u6cf0, \u7247\u5ca1\u6b63\u660e, \u5927\u7530\u8015\u53f8, \u68da\u7530\u3000\u7a14, \u5bfa\u672c\u5178\u5f18, \u897f\u6751\u7406\u6075\u5b50. \u81b5solitary fibrous tumor\u306e\uff11\u4f8b. \u7b2c23\u56de\u8179\u90e8\u653e\u5c04\u7dda\u7814\u7a76\u4f1a (2009. 6, \u5ca1\u5c71)
\n31. \u5c0f\u7530\u5c1a\u543e, \u5e73\u585a\u7fa9\u5eb7, , \u4e09\u6728\u5747, \u83ca\u6c60\u6075\u4e00, \u671b\u6708\u8f1d\u4e00. 3T-MRA\u306b\u304a\u3051\u308b\u8133\u52d5\u8108\u7624\u8a3a\u65ad\u7cbe\u5ea6\uff1a\u507d\u9670\u6027\u75c7\u4f8b\u306e\u691c\u8a0e. \u7b2c17\u56de\u65e5\u672cMR Angiography\u7814\u7a76\u4f1a (2009. 6, \u5927\u962a)
\n32. \u6ff1\u672c\u6cf0, \u7247\u5ca1\u6b63\u660e, \u83c5\u539f\u656c\u6587, \u4e95\u4e0a\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9752\u91ce\u7965\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u57ce\u6238\u502b\u4e4b. \u5b9a\u4f4d\u7167\u5c04\u3092\u884c\u3063\u305f\u539f\u767a\u6027\u80ba\u764c\u306b\u304a\u3051\u7167\u5c04\u524dFDG\u96c6\u7a4d\u7a0b\u5ea6\u3068\u518d\u767a\u5f62\u5f0f . \u7b2c20\u56de\u65e5\u672c\u9ad8\u7cbe\u5ea6\u5916\u90e8\u7167\u5c04\u7814\u7a76\u4f1a (2009. 7, \u4ed9\u53f0)
\n33. \u6ff1\u672c\u3000\u6cf0, \u7247\u5ca1\u6b63\u660e, \u4ed9\u6ce2\u8cb4\u654f, \u4e0a\u6d25\u5b5d\u592a\u90ce . \u30de\u30a4\u30af\u30ed\u30de\u30eb\u30c1\u30ea\u30fc\u30d5\u30b3\u30ea\u30e1\u30fc\u30bf\u3092\u7528\u3044\u305f\u8133\u5b9a\u4f4d\u7167\u5c04\u306b\u304a\u3051\u308b\u7dda\u91cf\u52fe\u914d\u306e\u8abf\u7bc0. \u7b2c18\u56de\u65e5\u672c\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u5b66\u4f1a (2009. 7, \u4ed9\u53f0)
\n34. \u7530\u53e3\u5343\u85cf, \u8d8a\u667a\u8a89\u53f8, \u897f\u5ddd\u6566, \u85e4\u4e95\u5d07, \u671b\u6708\u8f1d\u4e00. \u5f53\u9662\u306b\u304a\u3051\u308b\u4e2d\u67a2\u795e\u7d4c\u539f\u767a\u60aa\u6027\u30ea\u30f3\u30d1\u816b\uff08PCNSL\uff09\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c22\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a (2009. 9, \u4eac\u90fd)
\n35. \u4ed9\u6ce2\u8cb4\u654f, \u6ff1\u672c\u6cf0, \u4e0a\u6d25\u5b5d\u592a\u90ce, \u7247\u5ca1\u6b63\u660e, \u4e2d\u5c71\u91cd\u6a39, \u9808\u5185\u5149\u660e, \u9152\u4e95\u4f38\u4e5f. \u80ba\u5b9a\u4f4d\u653e\u5c04\u7dda\u6cbb\u7642\u5f8c\u5c40\u6240\u518d\u767a\u306b\u5bfe\u3059\u308b\u6551\u6e08\u624b\u8853\u306e\u691c\u8a0e. \u7b2c22\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a (2009. 9, \u4eac\u90fd)
\n36. \u6d66\u5cf6\u96c4\u4ecb, \u5409\u5ca1\u771f\u4e8c, \u8d77\u585a\u9999\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u6751\u7530\u7e41\u5229. \u5f53\u9662\u306b\u304a\u3051\u308b\u5589\u982d\u764c\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c22\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a (2009. 9, \u4eac\u90fd)
\n37. \u4e0a\u6d25\u5b5d\u592a\u90ce, \u6ff1\u672c \u6cf0, \u4e2d\u5c71\u3000\u91cd\u6a39, \u9808\u5185\u3000\u5149\u660e, \u4ed9\u6ce2\u3000\u8cb4\u654f, \u9152\u4e95\u3000\u4f38\u4e5f, \u7247\u5ca1\u3000\u6b63\u660e. \u65e9\u671f\u58f0\u9580\u90e8\u5589\u982d\u764c\u306b\u5bfe\u3059\u308b \u653e\u5c04\u7dda\u6cbb\u7642\u306e\u6cbb\u7642\u6210\u7e3e\u306e\u691c\u8a0e. \u7b2c22\u56de\u65e5\u672c\u653e\u5c04\u7dda\u816b\u760d\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a (2009. 9, \u4eac\u90fd)
\n38. \u4e2d\u6751\u8aa0\u6cbb, \u83ca\u6c60\u9686\u5fb3, \u77f3\u4e38\u826f\u5e83, \u66fd\u6211\u90e8\u4e00\u90ce, \u677e\u6728\u5f18\u91cf, \u5c71\u4e0b \u606d, \u6751\u4e0a\u5fe0\u53f8, \u68b6\u539f\u3000\u8aa0, \u5c0f\u4e80\u96c5\u5e83, \u5ddd\u53e3\u76f4\u4eba, \u5bae\u5ddd\u6b63\u7537. Microsphere Slit-dose\u6cd5\u3092\u57fa\u306b1\u70b9\u52d5\u8108\u63a1\u8840, \u9759\u8108\u63a1\u8840\u306b\u5bfe\u5fdc\u3057\u305f\u65b0\u3057\u3044\u5c40\u6240\u8133\u8840\u6d41\u5b9a\u91cf\u30bd\u30d5\u30c8\u306e\u958b\u767a. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n39. \u677e\u672c\u7f8e\u6075, \u4e95\u4e0a\u3000\u6b66, \u9752\u91ce\u7965\u53f8, \u83c5\u539f\u656c\u6587, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f. Uptake\u6642\u9593\u306e\u9055\u3044\u3092\u8003\u616e\u3057\u305fFDG-PET\u691c\u67fb\u306e\u753b\u50cf\u518d\u69cb\u6210\u6700\u9069\u5316. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n40. \u6ff1\u672c \u6cf0, \u7247\u5ca1\u6b63\u660e, \u65b0\u6d77\u54f2, \u91ce\u4e0a\u5c1a\u4e4b, \u4ed9\u6ce2\u8cb4\u654f, \u4e0a\u6d25\u5b5d\u592a\u90ce. \u653e\u5c04\u7dda\u6cbb\u7642\u6a5f\u5668\u66f4\u65b0\u3001PET\/CT\u5c0e\u5165\u524d\u5f8c\u306eIII\u671f\u975e\u5c0f\u7d30\u80de\u80ba\u764c\u306e\u540c\u6642\u5316\u5b66\u653e\u5c04\u7dda\u7642\u6cd5\u6210\u7e3e. \u7b2c48\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a (2009. 10, \u6a2a\u6d5c)
\n41. \u4e95\u4e0a\u7950\u99ac, \u9577\u5c3e\u5145\u5c55, \u6771\u91ce\u535a, \u7d30\u5ddd\u6d69\u5e73, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u671b\u6708\u8f1d\u4e00, \u6751\u702c\u7814\u4e5f\u3000\u4ed6. 3T MRI\u3092\u7528\u3044\u305f\u9673\u65e7\u6027\u5fc3\u7b4b\u6897\u585e\u3068\u5fc3\u7b4b\u5c40\u6240\u58c1\u904b\u52d5\u306e\u95a2\u4fc2\u306e\u691c\u8a0e. \u7b2c37\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a (2009. 10, \u6a2a\u6d5c)
\n42. \u83ca\u6c60\u6075\u4e00, \u4e09\u6728\u5747, \u5c0f\u7530\u5c1a\u543e, \u9ad8\u91ce\u660c\u5e73, \u5927\u4e0a\u53f2\u6717, \u6751\u702c\u7814\u4e5f. \u8133\u816b\u760d\u306e\u8840\u6d41\u60c5\u5831\u306e\u691c\u8a0e\uff1aT1\u3068T2*\u30c0\u30a4\u30ca\u30df\u30c3\u30af\u3092\u7528\u3044\u3066. \u7b2c37\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a (2009. 10, \u6a2a\u6d5c)
\n43. \u5c0f\u7530\u5c1a\u543e, \u4e09\u6728\u5747, \u83ca\u6c60\u6075\u4e00, \u671b\u6708\u8f1d\u4e00, \u5e73\u585a\u7fa9\u5eb7, \u6751\u702c\u7814\u4e5f. \u30b3\u30f3\u30d4\u30e5\u30fc\u30bf\u30fc\u30b7\u30df\u30e5\u30ec\u30fc\u30b7\u30e7\u30f3\u306b\u3088\u308b3T MRI\u306e\u8133\u7d44\u7e54\u30b3\u30f3\u30c8\u30e9\u30b9\u30c8\uff1a1.5T MRI\u3068\u306e\u6bd4\u8f03. \u7b2c37\u56de\u65e5\u672c\u78c1\u6c17\u5171\u9cf4\u533b\u5b66\u4f1a\u5927\u4f1a (2009. 10, \u6a2a\u6d5c)
\n44. \u5c0f\u5cf6\u3000\u660e\u5f66, \u767d\u77f3\u3000\u6cf0\u5b8f, \u4e0a\u7530\u3000\u5e78\u4ecb, \u5409\u672c\u3000\u653f\u5f18. 3T\u3000MRI\u88c5\u7f6e\u752832ch\u3000Cardiac\u3000Torso coil\u306e\u57fa\u790e\u7684\u691c\u8a0e. \u7b2c37\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a (2009. 10, \u5ca1\u5c71\u5e02)
\n45. \u6b66\u667a\u6075, \u5409\u5ca1\u771f\u4e8c, \u677e\u5742\u667a\u7f8e, \u6e05\u6c34\u8f1d\u5f66, \u6d66\u5cf6\u96c4\u4ecb, \u6751\u7530\u7e41\u5229, \u5175\u982d\u670b\u5b50, \u5e73\u7530\u96c5\u662d, \u6751\u4e0a\u6b63\u54f2, \u6d25\u7530\u5b5d\u6cbb, \u671b\u6708\u8f1d\u4e00. \u7652\u7740\u80ce\u76e4\u8853\u524d\u306e\u5185\u8178\u9aa8\u52d5\u8108\u30d0\u30eb\u30fc\u30f3\u585e\u6813\u8853\u306b\u3064\u3044\u3066. \u7b2c45\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a (2009. 10, \u548c\u6b4c\u5c71)
\n46. \u5175\u982d\u670b\u5b50. \u30a4\u30e1\u30fc\u30b8\u30a4\u30f3\u30bf\u30fc\u30d7\u30ea\u30c6\u30fc\u30b7\u30e7\u30f3\u30bb\u30c3\u30b7\u30e7\u30f3\u300c\u75c7\u4f8b5 \u9aa8\u5316\u6027\u7b4b\u708e\u300d\u30c7\u30a3\u30b9\u30ab\u30c3\u30b5\u30fc. \u7b2c45\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a (2009. 10, \u548c\u6b4c\u5c71)
\n47. \u5409\u5ca1\u771f\u4e8c, \u8d77\u585a\u9999\u5b50, \u6e05\u6c34\u8f1d\u5f66, \u6d66\u5cf6\u96c4\u4ecb, \u6751\u7530\u7e41\u5229. \u5341\u4e8c\u6307\u8178\u58c1\u306b\u5de8\u5927\u56ca\u80de\u6027\u816b\u7624\u3092\u5f62\u6210\u3057\u305fGroove pancreatitis\u306e\u4e00\u4f8b. \u7b2c45\u56de\u65e5\u672c\u533b\u5b66\u653e\u5c04\u7dda\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a (2009. 10, \u548c\u6b4c\u5c71)
\n48. \u5c0f\u4e80\u96c5\u5e83, \u5ddd\u53e3\u76f4\u4eba, \u68b6\u539f \u8aa0, \u6751\u4e0a\u5fe0\u53f8, \u5c71\u4e0b \u606d, \u677e\u6728\u5f18\u91cf, \u66fd\u6211\u90e8\u4e00\u90ce, \u77f3\u4e38\u826f\u5e83, \u83ca\u6c60\u9686\u5fb3, \u4e2d\u6751\u8aa0\u6cbb, \u5bae\u5ddd\u6b63\u7537. \u6025\u6027\u5fc3\u7b4b\u6897\u585e\u518d\u6f45\u6d41\u5f8c\u306b\u304a\u3051\u308bNH3PET\/CT\u3068MRI\u9045\u5ef6\u9020\u5f71\u306e\u6897\u585e\u5fc3\u7b4b\u691c\u51fa\u80fd\u306e\u6bd4\u8f03. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n49. \u9577\u5c3e\u5145\u5c55, \u6771\u91ce\u535a, \u57ce\u6238\u8f1d\u4ec1, \u5009\u7530\u8056, \u4e95\u4e0a\u7950\u99ac, \u7d30\u5ddd\u6d69\u5e73, \u671b\u6708\u8f1d\u4e00\u4ed6. \u5fc3\u7b4b\u30b7\u30f3\u30c1\u3068Tagged MRI\u306b\u3088\u308b\u865a\u8840\u6027\u5fc3\u7b4b\u75c7\u306e\u8840\u6d41\u3068\u6a5f\u80fd\u8a55\u4fa1. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n50. \u7d30\u5ddd\u6d69\u5e73,\u5009\u7530\u8056,\u57ce\u6238\u8f1d\u4ec1,\u4e95\u4e0a\u7950\u99ac,\u9577\u5c3e\u5145\u5c55,\u6771\u91ce\u535a,\u671b\u6708\u8f1d\u4e00. \u5fc3\u81d3CT\u306b\u3088\u308b\u5fc3\u7b4b\u865a\u8840\u8a55\u4fa1-SPECT\u3068\u306e\u5bfe\u6bd4-. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n51. \u6771\u91ce \u535a, \u671b\u6708 \u8f1d\u4e00, \u6e21\u8fba \u6d69\u6bc5, \u5ddd\u4e0a \u79c0\u751f, \u83ca\u6c60 \u9686\u5fb3. \u5fc3\u7b4bSPECT\u306b\u304a\u3051\u308b\u30a8\u30ad\u30b9\u30d1\u30fc\u30c8\u304a\u3088\u3073\u81ea\u52d5\u8a3a\u65ad\u306b\u3088\u308b\u30b9\u30b3\u30a2\u30ea\u30f3\u30b0\u30a2\u30c8\u30e9\u30b9\u4f5c\u6210. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n52. \u57ce\u6238\u502b\u4e4b, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9752\u91ce\u7965\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f, \u83c5\u539f\u656c\u6587. FDG negative\u4e73\u764c\u306e\u983b\u5ea6\u3068\u81e8\u5e8a\u6240\u898b, \u75c5\u7406\u6240\u898b\u306b\u3064\u3044\u3066. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n53. \u4e95\u4e0a\u3000\u6b66, \u83c5\u539f\u656c\u6587, \u9152\u4e95\u4f38\u4e5f, \u9752\u91ce\u7965\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u57ce\u6238\u502b\u4e4b, \u4ed9\u6ce2\u8cb4\u654f. \u4e73\u764c\u6839\u6cbb\u8853\u5f8c\u306e\u30d5\u30a9\u30ed\u30fc\u30a2\u30c3\u30d7\u306b\u304a\u3051\u308bFDG-PET\/CT\u306e\u610f\u7fa9\uff70\u5c40\u6240\u518d\u767a, \u9818\u57df\u30ea\u30f3\u30d1\u7bc0\u518d\u767a\u306e\u691c\u8a0e\uff70. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n54. \u83c5\u539f\u656c\u6587, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9752\u91ce\u7965\u53f8, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f. \u81b5\u5185\u5206\u6ccc\u816b\u760d\u306eFDG-PET\/\u9020\u5f71CT\u6240\u898b\u3068\u60aa\u6027\u5ea6\u3068\u306e\u95a2\u9023\u306b\u3064\u3044\u3066. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n55. \u9752\u91ce\u7965\u53f8, \u83c5\u539f\u656c\u6587, \u4e95\u4e0a\u3000\u6b66, \u9152\u4e95\u4f38\u4e5f, \u9ad8\u6a4b\u5fe0\u7ae0, \u4ed9\u6ce2\u8cb4\u654f. \u809d\u5916\u80c6\u7ba1\u764c\u306ePET-CT\u6240\u898b\u3068\u75c5\u7406\u6240\u898b\u306e\u5bfe\u6bd4. \u7b2c49\u56de\u65e5\u672c\u6838\u533b\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a (2009. 10, \u65ed\u5ddd)
\n56. \u5897\u539f\u3000\u6643, \u5bae\u5ddd\u6b63\u7537, \u83ca\u6c60\u9686\u5fb3, \u4e2d\u6751\u8aa0\u6cbb, \u5ca1\u7530\u3000\u5065, \u68ee\u672c\u88d5\u7d00, \u5cf0\u96ea\u6d69\u7d9a, \u65b0\u85e4\u6cf0\u53f2, \u6c60\u7530\u826f\u4e00. NH3 Myocardial PET-CT\u691c\u67fb\u306b\u304a\u3044\u3066Misregistration\u304c\u5fc3\u7b4b\u8840\u6d41\u5b9a\u91cf\u306b\u4e0e\u3048\u308b\u5f71\u97ff\u306b\u3064\u3044\u3066. \u7b2c29\u56de\u65e5\u672c\u6838\u533b\u5b66\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a (2009. 10, \u65ed\u5ddd)
\n57. \u5c71\u4e0b \u606d,\u677e\u6728\u5f18\u91cf,\u5ddd\u53e3\u76f4\u4eba,\u5c0f\u4e80\u96c5\u5e83,\u68b6\u539f \u8aa0,\u6751\u4e0a\u5fe0\u53f8,\u66fd\u6211\u90e8\u4e00\u90ce,\u77f3\u4e38\u826f\u5e83,\u83ca\u6c60\u9686\u5fb3,\u4e2d\u6751\u8aa0\u6cbb,\u5bae\u5ddd\u6b63\u7537. \u5f53\u9662\u306b\u304a\u3051\u308b\u30e8\u30fc\u30c9\u5185\u670d\u7642\u6cd5\u306e\u6cbb\u7642\u6210\u7e3e. \u7b2c47\u56de\u65e5\u672c\u764c\u6cbb\u7642\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a (2009. 10, \u6a2a\u6d5c)
\n58. \u5897\u539f\u3000\u6643, \u4e2d\u6751\u8aa0\u6cbb, \u83ca\u6c60\u9686\u5fb3, \u5ca1\u7530\u3000\u5065, \u68ee\u672c\u88d5\u7d00, \u5cf0\u96ea\u6d69\u7d9a, \u65b0\u85e4\u6cf0\u53f2, \u6c60\u7530\u826f\u4e00. Dynamic SPECT\u30c7\u30fc\u30bf\u3092\u7528\u3044\u305f\u8133\u8840\u6d41\u91cf\u6e2c\u5b9a\u6cd5\u306e\u9055\u3044\u304b\u3089\u751f\u3058\u308b\u5c40\u6240\u8133\u8840\u6d41\u91cf\u306e\u691c\u8a0e. \u7b2c37\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u79cb\u5b63\u5b66\u8853\u5927\u4f1a (2009. 10, \u5ca1\u5c71)
\n59. \u6700\u4e0a\u3000\u535a, \u4f50\u4e45\u9593\u97ff\u5b50, \u83c5\u539f\u793c\u5b50, \u4e95\u4e0a\u88d5\u7f8e, \u7c73\u6728\u6d69\u5b50, \u524d\u7530\u60e0\u7406\u5b50, \u6a9c\u5c71\u5c1a\u5df3, \u99ac\u5834\u6c99\u7e54, \u5929\u91ce\u5922\u7f8e, \u5927\u897f\u7950\u5b50, \u6c5f\u91cc\u53e3\u7f8e\u6c5f, \u5c0f\u91ce\u6c60\u88d5\u7f8e\u5b50, \u4f50\u4f2f\u3048\u307f, \u5ddd\u4e0a\u58fd\u662d, \u9577\u5c3e \u5145\u5c55. \u30de\u30f3\u30e2\u30b0\u30e9\u30d5\u30a3\u691c\u8a3a\u7e70\u308a\u8fd4\u3057\u53d7\u8a3a\u306b\u3088\u308a\u7d4c\u5e74\u5909\u5316\u304c\u89b3\u5bdf\u3067\u304d\u305f\u767a\u898b\u4e73\u764c\u306e\u691c\u8a0e. \u7b2c19\u56de\u65e5\u672c\u4e73\u764c\u691c\u8a3a\u5b66\u4f1a (2009. 11, \u672d\u5e4c)
\n————\u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09\u3001\u8b1b\u6f14\u3001\u7814\u7a76\u52a9\u6210\u3001\u53d7\u8cde\u306f2009\u5e74\u696d\u7e3e\u3000\u305d\u306e2<\/a>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u25a0\u8ad6\u6587\u30fb\u8457\u66f8 \u539f\u8457\u8ad6\u6587 \u7dcf\u8aac, \u4ed6 \u75c7\u4f8b\u5831\u544a \u8457\u66f8 \u25a0\u3000\u5b66\u4f1a\u30fb\u7814\u7a76\u4f1a\u767a\u8868 \u56fd\u969b\u5b66\u4f1a \u56fd\u5185\u5b66\u4f1a\uff08\u5168\u56fd\uff09 \u56fd\u5185\u5b66\u4f1a\uff08\u5730\u65b9\u4f1a\uff09 \u25a0 \u8b1b\u6f14 \u25a0 \u7814\u7a76\u52a9\u6210 \u25a0 \u53d7\u8cde ————&#82 […]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[20],"tags":[],"class_list":["post-5445","post","type-post","status-publish","format-standard","hentry","category-20"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts\/5445","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/comments?post=5445"}],"version-history":[{"count":0,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/posts\/5445\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/media?parent=5445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/categories?post=5445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.m.ehime-u.ac.jp\/school\/radiology\/wp-json\/wp\/v2\/tags?post=5445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}